Avantor, Inc.

NYSE:AVTR

Medical - Instruments & Supplies

Healthcare
$15.37 +0.69%

+$0.07 today

Market cap
$10.41B
Beta
0.96
P/E (TTM)
-11.7
EPS (TTM)
-$0.81
52W Low $7.27High $15.93

Volume 5.94M

Average 9.44M

AVTR Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Avantor, Inc.NYSE: AVTR

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin holds steady near 7.2%

Operating margin was 7.2% in Q2 FY2026, down 0.5 pp from a year earlier. On a trailing-twelve-month basis it was -4.4%, down 19.9 pp year over year. Over 3 fiscal years it narrowed by 18.8 pp.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 11 analysts of 13.3% for the fiscal year ending Dec 2026, up from -3.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
7.2%-0.1 pp QoQ
Last fiscal yearDec 2025
-3.8%-19.7 pp YoY
LTMJun 2026
-4.4%-19.9 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.5 pp+52.7 pp+53.2 pp
1 year-19.7 pp+17.1 pp+36.8 pp
3 years-18.8 pp+17.9 pp+36.7 pp
5 years+18.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-3.8%
Year-over-year change
-19.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How AVTR compares with its peers on the latest reported figures

  • AVTR's LTM Jun 2026 operating margin of -4.4% is the 7th highest of the 9 companies compared; the peer median is 10.7%.
  • Its year-over-year change of -19.9 pp is the 8th highest of 9, against a peer median of -0.2 pp.
  • Over three fiscal years its change of -18.8 pp compares with a peer median of -6.6 pp.
AVTR Competitors Peer median
Operating Margin for AVTR and competitors
Company Period LTM level YoY 3-year change
WSTWest Pharmaceutical Services, Inc.LTM Jun 202620.6% -0.5 pp-6.4 pp
DHRDanaher CorporationLTM Sep 202620.4% -1.7 pp-7.4 pp
STVNStevanato Group S.p.A.LTM Jun 202616.1% +0.0 pp-3.5 pp
CRLCharles River Laboratories International, Inc.LTM Jun 202612.3% +9.3 pp-3.7 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 20269.1% +0.3 pp-6.8 pp
RGENRepligen CorporationLTM Jun 20268.3% +11.9 pp-20.0 pp
AVTRAvantor, Inc.LTM Jun 2026-4.4% -19.9 pp-18.8 pp
BLFSBioLife Solutions, Inc.LTM Mar 2026-10.9% -3.8 pp+6.6 pp
AZTAAzenta, Inc.LTM Sep 2026-27.7% -26.6 pp-15.7 pp
Peer median (excluding AVTR) 10.7%-0.2 pp-6.6 pp

Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue7.39B7.51B6.97B6.78B6.55B
Cost of Revenue4.88B4.91B4.6B4.5B4.41B
Gross Profit2.5B2.6B2.36B2.28B2.14B
Gross Margin33.9%34.6%33.9%33.6%32.7%
Research & Development00000
Selling, General & Admin1.53B1.47B1.51B1.64B1.6B
Operating Expenses1.53B1.47B1.67B1.19B2.39B
Depreciation & Amortization379.2M405.5M402.3M405.5M410.2M
EBITDA1.35B1.52B1.1B1.48B138.7M
EBITDA Margin18.3%20.3%15.8%21.8%2.1%
Operating Income972.2M1.13B696.4M1.08B(246.2M)
Operating Margin13.2%15.0%10.0%16.0%-3.8%
Interest Income00000
Interest Expense217.4M265.8M284.8M218.8M169.8M
Other Income / Expenses(219.2M)(279.1M)(285.9M)(230.9M)(195.1M)
Income Before Tax753M851.1M410.5M853.9M(441.3M)
Pre-Tax Margin10.2%11.3%5.9%12.6%-6.7%
Income Tax Expense180.4M164.6M89.4M142.4M88.9M
Net Income572.6M686.5M321.1M711.5M(530.2M)
Net Margin7.8%9.1%4.6%10.5%-8.1%
EPS (Basic)0.861.020.481.05(0.78)
EPS (Diluted)0.851.010.471.04(0.78)
Weighted Avg Shares590.5M650.9M675.6M680.3M678M
Weighted Avg Shares (Diluted)599.6M679.4M678.4M681.9M679.3M

Avantor, Inc.

NYSE:AVTR

Intrinsic Alpha fair value

Locked

Current Price

$15.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.